Joanna E. Sokolowska-Drozd

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 150 publications

Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

Journal: Leukemia & lymphoma

Published: August 10, 2026

Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era - a real-world analysis by the Polish Adult Lukemia Study Group.

Risk factors affecting the clinical course of COVID-19 in patients with lymphoid malignancies in the Omicron subvariants era - a real-world analysis by the Polish Adult Lukemia Study Group.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: June 30, 2026

The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.

The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.

Journal: British journal of haematology

Published: May 15, 2026

Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone-a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT.

Journal: Bone marrow transplantation

Published: April 15, 2026

Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.

Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT.

Journal: American journal of hematology

Published: March 09, 2026

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

Journal: American journal of hematology

Published: February 03, 2026

Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Journal: The Lancet. Haematology

Published: January 12, 2026

Primary Adrenal Gland Lymphoma: Report of 13 Cases-A Retrospective Multicenter Polish Lymphoma Research Group Analysis.

Primary Adrenal Gland Lymphoma: Report of 13 Cases-A Retrospective Multicenter Polish Lymphoma Research Group Analysis.

Journal: Life (Basel, Switzerland)

Published: December 18, 2025

Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT.

Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT.

Journal: Bone marrow transplantation

Published: December 14, 2025

Chronic lymphocytic leukemia mimicking lung carcinoma: an unusual extranodal and extramedullary presentation of a frequent hematological neoplasm.

Chronic lymphocytic leukemia mimicking lung carcinoma: an unusual extranodal and extramedullary presentation of a frequent hematological neoplasm.

Journal: Polish archives of internal medicine

Published: December 01, 2025

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT.

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT.

Journal: Bone marrow transplantation

Published: December 01, 2025

Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Journal: Bone marrow transplantation

Published: November 30, 2025

Showing 1-12 of 150

Last Updated: 09/26/2026